-
V.
Blazevic,
M.
Heino,
A.
Lagerstedt,
A.
Ranki,
K.
Krohn
(1996)
Interleukin-10 gene expression induced by HIV-1 Tat and Rev in the cells of HIV-1 infected individuals.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 13 3
-
S.
Pelton,
D.
Johnson,
E.
Chadwick,
Z.
Baldwin,
R.
Yogev
(1999)
A one year experience: T cell responses and viral replication in children with advanced human immunodeficiency virus type 1 disease treated with combination therapy including ritonavir.
The Pediatric infectious disease journal, 18 7
-
R.
Yarchoan,
K.
Weinhold,
H.
Lyerly,
E.
Gelmann,
R.
Blum,
G.
Shearer,
H.
Mitsuya,
J.
Collins,
C.
Myers,
R.
Klecker,
P.
Markham,
D.
Durack,
S.
Lehrman,
D.
Barry,
M.
Fischl,
R.
Gallo,
D.
Bolognesi,
S.
Broder
(1986)
ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX
The Lancet, 327
-
J.
Angel,
Ajay
Kumar,
K.
Parato,
L.
Filion,
F.
Diaz-Mitoma,
P.
Daftarian,
Ba'
Pham,
E.
Sun,
J.
Leonard,
D.
Cameron
(1998)
Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir.
The Journal of infectious diseases, 177 4
-
C.
Mackall,
T.
Fleisher,
Margaret
Brown,
M.
Andrich,
Clara
Chen,
I.
Feuerstein,
M.
Horowitz,
I.
Magrath,
A.
Shad,
S.
Steinberg,
L.
Wexler,
R.
Gress
(1995)
Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy.
The New England journal of medicine, 332 3
-
S.
Sei,
S.
Sandelli,
G.
Theofan,
S.
Ratto-Kim,
M.
Kumagai,
L.
Loomis-Price,
J.
Cox,
P.
Jarosinski,
C.
Walsek,
P.
Brouwers,
D.
Venzon,
J.
Xu,
P.
Pizzo,
R.
Moss,
M.
Robb,
L.
Wood
(1999)
Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infection.
The Journal of infectious diseases, 180 3
-
C.
Pitcher,
C.
Quittner,
D.
Peterson,
M.
Connors,
R.
Koup,
V.
Maino,
L.
Picker
(1999)
HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
Nature Medicine, 5
-
M.
Dalod,
M.
Harzic,
I.
Pellegrin,
B.
Dumon,
B.
Hoen,
D.
Séréni,
J.
Deschemin,
J.
Levy,
A.
Venet,
E.
Gomard
(1998)
Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy.
The Journal of infectious diseases, 178 1
-
F.
Diaz-Mitoma,
A.
Kumar,
S.
Karimi,
M.
Kryworuchko,
M.
Daftarian,
W.
Creery,
L.
Filion,
W.
Cameron
(1995)
Expression of IL‐10, IL‐4 and interferon‐gamma in unstimulated and mitogen‐stimulated peripheral blood lymphocytes from HIV‐seropositive patients
Clinical & Experimental Immunology, 102
-
J.
Stuart,
W.
Slieker,
G.
Rijkers,
A.
Noest,
C.
Boucher,
M.
Suur,
R.
Boer,
S.
Geelen,
H.
Scherpbier,
N.
Hartwig,
H.
Hooijkaas,
M.
Roos,
B.
GRAEFF‐MEEDER,
R.
Groot
(1998)
Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy
AIDS, 12
-
Ligia
Pinto,
J.
Berzofsky,
K.
Fowke,
Richard
Little,
Fiorentino
Merced-Galindez,
Rachel
Humphrey,
J.
Ahlers,
Nancy
Dunlop,
Roger
Cohen,
Seth
Steinberg,
Peter
Nara,
Gene
Shearer,
R.
Yarchoan
(1999)
HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patients.
AIDS, 13 15
-
P.
Volberding,
S.
Deeks
(1998)
Antiretroviral therapy for HIV infection: promises and problems.
JAMA, 279 17
-
M.
Markowitz,
M.
Saag,
W.
Powderly,
A.
Hurley,
A.
Hsu,
J.
Valdes,
D.
Henry,
F.
Sattler,
Anthony
Marca,
J.
Leonard,
D.
Ho
(1995)
A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection.
The New England journal of medicine, 333 23
-
J.
Chehimi,
S.
Starr,
I.
Frank,
A.
D’Andrea,
Xiaojing
Ma,
R.
Macgregor,
J.
Sennelier,
G.
Trinchieri
(1994)
Impaired interleukin 12 production in human immunodeficiency virus- infected patients
The Journal of Experimental Medicine, 179
-
T.
Wendland,
H.
Furrer,
P.
Vernazza,
K.
Frutig,
Anna
Christen,
L.
Matter,
R.
Malinverni,
W.
Pichler
(1999)
HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia.
AIDS, 13 14
-
E.
Stylianou,
P.
Aukrust,
Dag
Kvale,
Fredrik
Müller,
S.
Frøland
(1999)
IL‐10 in HIV infection: increasing serum IL‐10 levels with disease progression—down‐regulatory effect of potent anti‐retroviral therapy
Clinical & Experimental Immunology, 116
-
Claire
Chougnet,
Thomas
Wynn,
Mario
Clerici,
Alan
Landay,
H.
Kessler,
Janice
Rusnak,
Gregory
Melcher,
Alan
Sher,
Gene
Shearer
(1996)
Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus.
The Journal of infectious diseases, 174 1
-
S.
Fleury,
G.
Pantaleo
(1999)
T cell regeneration in HIV-infected subjects under highly active antiretroviral therapy (review).
International journal of molecular medicine, 4 1
-
D.
Douek,
R.
McFarland,
P.
Keiser,
Earl
Gage,
J.
Massey,
B.
Haynes,
M.
Polis,
A.
Haase,
M.
Feinberg,
J.
Sullivan,
B.
Jamieson,
J.
Zack,
L.
Picker,
R.
Koup
(1998)
Changes in thymic function with age and during the treatment of HIV infection
Nature, 396
-
C.
Isada,
L.
Calabrese
(1999)
AIDS update 1999: viral reservoirs and immune-based therapies.
Cleveland Clinic journal of medicine, 66 5
-
D.
Richman
(1999)
The challenge of immune control of immunodeficiency virus.
The Journal of clinical investigation, 104 6
-
F.
Miedema,
A.
Petit,
F.
Terpstra,
Jan
Karel,
M.
Eeftinck,
Schattenkerko
Wolf,
Bert
Al,
M.
Roos,
J.
Lange,
S.
Danner,
J.
Goudsmit,
Peter
Th,
Schellekens
(1988)
Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.
The Journal of clinical investigation, 82 6
-
S.
Kalams,
P.
Goulder,
A.
Shea,
N.
Jones,
A.
Trocha,
G.
Ogg,
B.
Walker
(1999)
Levels of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Effector and Memory Responses Decline after Suppression of Viremia with Highly Active Antiretroviral Therapy
Journal of Virology, 73
-
B.
Autran,
G.
Carcelain,
T.
Li,
C.
Blanc,
D.
Mathez,
R.
Tubiana,
C.
Katlama,
P.
Debré,
J.
Leibowitch
(1997)
Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.
Science, 277 5322
-
M.
Clerici,
A.
Sarin,
J.
Berzofsky,
A.
Landay,
H.
Kessler,
Farah
Hashemi,
C.
Hendrix,
S.
Blatt,
J.
Rusnak,
M.
Dolan,
R.
Coffman,
P.
Henkart,
G.
Shearer
(1996)
Antigen‐stimulated apoptotic T‐cell death in HIV infection is selective for CD4+T cells, modulated by cytokines and effected by lymphotoxin
AIDS, 10
-
L.
Bisset,
M.
Rothen,
H.
Joller-Jemelka,
R.
Dubs,
P.
Grob,
M.
Opravil
(1997)
Change in circulating levels of the chemokines macrophage inflammatory proteins 1α and 1β, RANTES, monocyte chemotactic protein‐1 and interleukin‐16 following treatment of severely immunodeficient HIV‐infected individuals with indinavir
AIDS, 11
-
Thomas
Evans,
W.
Bonnez,
H.
Soucier,
Theresa
Fitzgerald,
David
Gibbons,
R.
Reichman
(1998)
Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells.
Antiviral research, 39 3
-
E.
Rosenberg,
J.
Billingsley,
A.
Caliendo,
Steve
Boswell,
P.
Sax,
Spyros
Kalams,
B.
Walker
(1997)
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.
Science, 278 5342
-
P.
Zhou,
S.
Goldstein,
K.
Devadas,
D.
Tewari,
A.
Notkins
(1997)
Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: Inhibition of mRNA expression
Nature Medicine, 3
-
Clive
Gray,
Jody
Lawrence,
Jonathan
Schapiro,
J.
Altman,
John
Altman,
Mark
Winters,
Meg
Crompton,
M.
Loi,
S.
Kundu,
Mark
Davis,
T.
Merigan
(1999)
Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
Journal of immunology, 162 3
-
Oscar
Pontesilli,
S.
Kerkhof-Garde,
D.
Notermans,
Norbert
Foudraine,
M.
Roos,
M.
Klein,
S.
Danner,
J.
Lange,
Frank
Miedema
(1999)
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy.
The Journal of infectious diseases, 180 1
-
C.
Chougnet,
K.
Fowke,
B.
Mueller,
Sharon
Smith,
J.
Zuckerman,
Shirley
Jankelevitch,
S.
Steinberg,
N.
Luban,
P.
Pizzo,
G.
Shearer
(1998)
Protease inhibitor and triple‐drug therapy: cellular immune parameters are not restored in pediatric AIDS patients after 6 months of treatment
AIDS, 12
-
M.
Clerici,
N.
Stocks,
R.
Zajac,
R.
Boswell,
Denise
Bernstein,
Dean
Mann,
Gene
Shearer,
J.
Berzofsky
(1989)
Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals
Nature, 339
-
G.
Ortiz,
D.
Nixon,
A.
Trkola,
J.
Binley,
X.
Jin,
S.
Bonhoeffer,
P.
Kuebler,
S.
Donahoe,
M.
Demoitié,
W.
Kakimoto,
T.
Ketas,
B.
Clas,
J.
Heymann,
L.
Zhang,
Y.
Cao,
A.
Hurley,
J.
Moore,
D.
Ho,
M.
Markowitz
(1999)
HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy.
The Journal of clinical investigation, 104 6
-
Jason
Marshall,
J.
Chehimi,
G.
Gri,
J.
Kostman,
L.
Montaner,
G.
Trinchieri
(1999)
The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals.
Blood, 94 3
-
I.
Mezzaroma,
M.
Carlesimo,
E.
Pinter,
C.
Alario,
G.
Sacco,
D.
Muratori,
M.
Bernardi,
R.
Paganelli,
F.
Aiuti
(1999)
Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease.
AIDS, 13 10